March 19, 2026 article Glomérulonéphrite primitive à dépôts mésangiaux d’immunoglobulines A Encyclopédie médico-chirurgicale. Néphrologie DOI: 10.1016/s1762-0945(25)47597-4 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 12 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases 2021 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access cited by 2 patents 827 citations Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 334 citations Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial 2023 The Lancet article Medicine Renal Diseases and Glomerulopathies Open access 305 citations IgA nephropathy 2023 Nature Reviews Disease Primers review Medicine Renal Diseases and Glomerulopathies Open access 246 citations After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy 2020 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access cited by 2 patents 214 citations KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV) 2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 161 citations A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy 2024 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 137 citations Treatment of patients with IgA nephropathy: a call for a new paradigm 2025 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 76 citations Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy 2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access 61 citations Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial 2023 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 58 citations Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy 2023 Kidney International Reports article Medicine Renal Diseases and Glomerulopathies Open access 26 citations #425 Felzartamab (anti-CD38) in patients with IgA Nephropathy—interim results from the IGNAZ study 2024 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies cited by 1 patent 13 citations 12 results